Evidence map›Paper›PMID 36239007›Full record

ArticleJournal of cosmetic dermatology2023

Herpes zoster and alopecia areata following mRNA BNT162b2 COVID-19 vaccine: Controversial immune effects.

Fabrizio Martora, Luigi Fornaro, Vincenzo Picone, Dario Marasca, Maurizio Gargiulo, Maria Carmela Annunziata, Gabriella Fabbrocini, Claudio Marasca

Abstract readLetter
In one paragraph

Article in Journal of cosmetic dermatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Alopecia areata following COVID-19 vaccine: a systematic review.European journal of medical research · 2024
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.Clinical, cosmetic and investigational dermatology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fabrizio MartoraDermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.ORCID 0000-0003-2523-050X
Luigi FornaroDermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Vincenzo PiconeDermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.ORCID 0000-0002-8137-8392
Dario MarascaDepartment of Dentistry, University Hospital Federico II, Naples, Italy.
Maurizio GargiuloUnit of Maxillofacial Surgery, Department of Medicine and Surgery, A. Cardarelli Hospital, Naples, Italy.
Maria Carmela AnnunziataDermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Gabriella FabbrociniDermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.ORCID 0000-0002-0064-1874
Claudio MarascaDermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alopecia AreataCOVID-19COVID-19 VaccinesHerpes ZosterBNT162 VaccineHerpesvirus 3, HumanHumansRNA, MessengerBNT162 VaccineCOVID-19 VaccinesRNA, Messengeralopecia areataCOVID-19herpes zostervaccine

Identifiers

PMID36239007
PMCPMC9874646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.